Thus, some mechanistic overlap between CPVT and LQTS caused by CaM mutations likely exist, and how arrhythmogenic CaM mutations manifest probably depends on their relative effects on RyR2, CaV1.2, and other CaM-regulated targets. Here, RYR2 is linked to familial long QT syndrome.